{
  "data": [
    {
      "LRT": 0.27,
      "alt": "G",
      "chr": "chr2",
      "end": 29222174,
      "ref": "G",
      "CADD": 0.66,
      "REVEL": 0.42,
      "start": 29222075,
      "SIFT4G": 0.89,
      "GenBank": "NM_004304",
      "PROVEAN": 0.96,
      "variant": "I9402R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.19,
      "fathmm-MKL": 0.82,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.71],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.23
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.63],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.16
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.06],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.53
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.16, -0.17, -0.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.73,
            "FE_Bind_mean": -0.72
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.11, -0.85, -0.96],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.14,
            "FE_Bind_mean": -0.26
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.13, -1.15, -0.41],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.08,
            "FE_Bind_mean": -0.83
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.26,
      "Polyphen2_HDIV": 0.58,
      "Polyphen2_HVAR": 0.21,
      "MutationAssessor": 0.71,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.66,
      "alt": "A",
      "chr": "chr2",
      "end": 29222857,
      "ref": "C",
      "CADD": 0.27,
      "REVEL": 0.55,
      "start": 29222886,
      "SIFT4G": 0.57,
      "GenBank": "NM_004304",
      "PROVEAN": 0.87,
      "variant": "A7679M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.69,
      "fathmm-MKL": 0.87,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.02],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.16],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.19
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.83],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.59
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.07, -0.71, -0.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.68,
            "FE_Bind_mean": -0.89
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.45, -0.41, -0.36],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -0.07
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.02, -0.26, -0.23],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.76,
            "FE_Bind_mean": -0.06
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.62,
      "Polyphen2_HDIV": 0.18,
      "Polyphen2_HVAR": 0.31,
      "MutationAssessor": 0.19,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.16,
      "alt": "T",
      "chr": "chr2",
      "end": 29222342,
      "ref": "C",
      "CADD": 0.69,
      "REVEL": 0.61,
      "start": 29222543,
      "SIFT4G": 0.06,
      "GenBank": "NM_004304",
      "PROVEAN": 0.05,
      "variant": "B7505E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.22,
      "fathmm-MKL": 0.98,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.66],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.99
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.01],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.12],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.23, -0.55, -0.48],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.05,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.56, -0.17, -0.48],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.51,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.38, -1.09, -0.53],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.07,
            "FE_Bind_mean": -1.17
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.43,
      "Polyphen2_HDIV": 0.75,
      "Polyphen2_HVAR": 0.49,
      "MutationAssessor": 0.55,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.49,
      "alt": "C",
      "chr": "chr2",
      "end": 29222419,
      "ref": "A",
      "CADD": 0.52,
      "REVEL": 0.82,
      "start": 29222934,
      "SIFT4G": 0.56,
      "GenBank": "NM_004304",
      "PROVEAN": 0.16,
      "variant": "B2163A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.47,
      "fathmm-MKL": 0.89,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.05],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.55
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.26],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.61],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.11
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.74, -0.13, -1.19],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -0.37
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.38, -0.49, -0.83],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.62, -0.91, -0.44],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -1.07
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.13,
      "Polyphen2_HDIV": 0.61,
      "Polyphen2_HVAR": 0.51,
      "MutationAssessor": 0.58,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.99,
      "alt": "A",
      "chr": "chr2",
      "end": 29222235,
      "ref": "G",
      "CADD": 0.93,
      "REVEL": 0.96,
      "start": 29222793,
      "SIFT4G": 0.16,
      "GenBank": "NM_004304",
      "PROVEAN": 0.84,
      "variant": "L2084E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.79,
      "fathmm-MKL": 0.89,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.25],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.83
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.47],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.39
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.31
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.63, -1.02, -0.85],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.03,
            "FE_Bind_mean": -0.43
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.54, -0.58, -0.81],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.32,
            "FE_Bind_mean": -1.15
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.91, -1.18, -0.48],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.72,
            "FE_Bind_mean": -0.31
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.82,
      "Polyphen2_HDIV": 0.93,
      "Polyphen2_HVAR": 0.93,
      "MutationAssessor": 0.34,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.76,
      "alt": "C",
      "chr": "chr2",
      "end": 29222791,
      "ref": "G",
      "CADD": 0.54,
      "REVEL": 0.84,
      "start": 29222835,
      "SIFT4G": 0.34,
      "GenBank": "NM_004304",
      "PROVEAN": 0.81,
      "variant": "L4273E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.57,
      "fathmm-MKL": 0.74,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.45
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.88],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.19
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.23],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.43
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.64, -0.61, -1.02],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.39
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.42, -0.85, -0.25],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.15,
            "FE_Bind_mean": -0.49
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.15, -0.76, -0.32],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.53,
            "FE_Bind_mean": -0.43
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.65,
      "Polyphen2_HDIV": 0.26,
      "Polyphen2_HVAR": 0.15,
      "MutationAssessor": 0.57,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.26,
      "alt": "T",
      "chr": "chr2",
      "end": 29222265,
      "ref": "C",
      "CADD": 0.53,
      "REVEL": 0.33,
      "start": 29222287,
      "SIFT4G": 0.35,
      "GenBank": "NM_004304",
      "PROVEAN": 0.19,
      "variant": "P5521K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.11,
      "fathmm-MKL": 0.81,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.09],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.12
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.86],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.56
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.66, -0.72, -0.17],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.87,
            "FE_Bind_mean": -0.56
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.85, -0.32, -0.74],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.26,
            "FE_Bind_mean": -0.27
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.43, -1.06, -1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -0.04
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.24,
      "Polyphen2_HDIV": 0.71,
      "Polyphen2_HVAR": 0.46,
      "MutationAssessor": 0.94,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.75,
      "alt": "T",
      "chr": "chr2",
      "end": 29222181,
      "ref": "C",
      "CADD": 0.06,
      "REVEL": 0.39,
      "start": 29222576,
      "SIFT4G": 0.77,
      "GenBank": "NM_004304",
      "PROVEAN": 0.32,
      "variant": "I9335A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.98,
      "fathmm-MKL": 0.74,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.88],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.51
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.46],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.84
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.97],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.07, -0.45, -0.73],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.17,
            "FE_Bind_mean": -0.89
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.73, -1.17, -0.36],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.22,
            "FE_Bind_mean": -0.45
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.19, -0.74, -0.85],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.61,
            "FE_Bind_mean": -0.54
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.72,
      "Polyphen2_HDIV": 0.87,
      "Polyphen2_HVAR": 0.82,
      "MutationAssessor": 0.36,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.31,
      "alt": "G",
      "chr": "chr2",
      "end": 29222690,
      "ref": "A",
      "CADD": 0.82,
      "REVEL": 0.12,
      "start": 29222451,
      "SIFT4G": 0.56,
      "GenBank": "NM_004304",
      "PROVEAN": 0.14,
      "variant": "B7108R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.18,
      "fathmm-MKL": 0.67,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.45],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.35],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.85
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.17, -0.59, -1.18],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.75,
            "FE_Bind_mean": -0.07
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.49, -0.04, -0.59],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.08,
            "FE_Bind_mean": -0.72
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.81, -0.37, -0.57],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.65,
            "FE_Bind_mean": -0.99
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.38,
      "Polyphen2_HDIV": 0.48,
      "Polyphen2_HVAR": 0.62,
      "MutationAssessor": 0.14,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.86,
      "alt": "G",
      "chr": "chr2",
      "end": 29222249,
      "ref": "G",
      "CADD": 0.22,
      "REVEL": 0.84,
      "start": 29222833,
      "SIFT4G": 0.09,
      "GenBank": "NM_004304",
      "PROVEAN": 0.32,
      "variant": "C4972E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.09,
      "fathmm-MKL": 0.91,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.47],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.41
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.99],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.69
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.03],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.16
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.93, -1.17, -0.21],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.32,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.36, -1.04, -0.94],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.01,
            "FE_Bind_mean": -0.77
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.62, -0.48, -0.67],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.43,
            "FE_Bind_mean": -0.45
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.29,
      "Polyphen2_HDIV": 0.14,
      "Polyphen2_HVAR": 0.55,
      "MutationAssessor": 0.34,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.49,
      "alt": "G",
      "chr": "chr2",
      "end": 29222843,
      "ref": "A",
      "CADD": 0.68,
      "REVEL": 0.15,
      "start": 29222047,
      "SIFT4G": 0.62,
      "GenBank": "NM_004304",
      "PROVEAN": 0.09,
      "variant": "P9790R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.04,
      "fathmm-MKL": 0.66,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.19],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.13
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.38],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.16
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.25],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.14
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.06, -0.38, -0.37],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -0.36
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.93, -0.34, -1.08],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.61,
            "FE_Bind_mean": -0.47
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.69, -0.01, -0.63],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.29,
            "FE_Bind_mean": -0.67
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.25,
      "Polyphen2_HDIV": 0.56,
      "Polyphen2_HVAR": 0.37,
      "MutationAssessor": 0.36,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.16,
      "alt": "G",
      "chr": "chr2",
      "end": 29222561,
      "ref": "G",
      "CADD": 0.38,
      "REVEL": 0.24,
      "start": 29222207,
      "SIFT4G": 0.19,
      "GenBank": "NM_004304",
      "PROVEAN": 0.28,
      "variant": "Q8281R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.17,
      "fathmm-MKL": 0.67,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.37],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.28],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.08],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.72, -0.12, -1.18],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.52,
            "FE_Bind_mean": -1.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.62, -0.08, -0.64],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.54,
            "FE_Bind_mean": -0.28
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.54, -1.19, -1.07],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.46,
            "FE_Bind_mean": -0.06
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.22,
      "Polyphen2_HDIV": 0.86,
      "Polyphen2_HVAR": 0.06,
      "MutationAssessor": 0.94,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.83,
      "alt": "A",
      "chr": "chr2",
      "end": 29222907,
      "ref": "A",
      "CADD": 0.01,
      "REVEL": 0.11,
      "start": 29222972,
      "SIFT4G": 0.65,
      "GenBank": "NM_004304",
      "PROVEAN": 0.52,
      "variant": "B8454K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.82,
      "fathmm-MKL": 0.86,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.59],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.88
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.33],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.42
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.03],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.36
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.73, -0.98, -0.01],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.89,
            "FE_Bind_mean": -0.67
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.64, -0.07, -1.17],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.39,
            "FE_Bind_mean": -0.55
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.65, -1.19, -0.99],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.41,
            "FE_Bind_mean": -0.76
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.25,
      "Polyphen2_HDIV": 0.47,
      "Polyphen2_HVAR": 0.99,
      "MutationAssessor": 0.88,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.85,
      "alt": "G",
      "chr": "chr2",
      "end": 29222447,
      "ref": "G",
      "CADD": 0.88,
      "REVEL": 0.66,
      "start": 29222779,
      "SIFT4G": 0.89,
      "GenBank": "NM_004304",
      "PROVEAN": 0.14,
      "variant": "L4621E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.09,
      "fathmm-MKL": 0.77,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.13],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.94
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.48],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.19
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.28],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.16
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.15, -1.04, -0.67],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.68,
            "FE_Bind_mean": -0.34
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.85, -0.93, -0.35],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.42,
            "FE_Bind_mean": -0.67
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.78, -0.16, -0.12],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.73,
            "FE_Bind_mean": -0.44
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.44,
      "Polyphen2_HDIV": 0.99,
      "Polyphen2_HVAR": 0.89,
      "MutationAssessor": 0.88,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.45,
      "alt": "C",
      "chr": "chr2",
      "end": 29222744,
      "ref": "G",
      "CADD": 0.63,
      "REVEL": 0.88,
      "start": 29222667,
      "SIFT4G": 0.63,
      "GenBank": "NM_004304",
      "PROVEAN": 0.65,
      "variant": "Q2565A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.06,
      "fathmm-MKL": 0.93,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.14],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.71],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.05
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.73],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.04
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.56, -1.19, -0.77],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.81,
            "FE_Bind_mean": -0.13
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.99, -1.03, -0.23],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.14
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.95, -0.11, -0.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.34
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.14,
      "Polyphen2_HDIV": 0.43,
      "Polyphen2_HVAR": 0.24,
      "MutationAssessor": 0.91,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.98,
      "alt": "C",
      "chr": "chr2",
      "end": 29222702,
      "ref": "G",
      "CADD": 0.17,
      "REVEL": 0.54,
      "start": 29222623,
      "SIFT4G": 0.51,
      "GenBank": "NM_004304",
      "PROVEAN": 0.94,
      "variant": "B6156A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.83,
      "fathmm-MKL": 0.78,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.97],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.14
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.19],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.74
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.94],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.63
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.85, -1.17, -1.06],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.29,
            "FE_Bind_mean": -0.53
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.88, -0.66, -0.83],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.24,
            "FE_Bind_mean": -0.15
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.19, -0.37, -0.82],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.21,
            "FE_Bind_mean": -0.59
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.58,
      "Polyphen2_HDIV": 0.45,
      "Polyphen2_HVAR": 0.82,
      "MutationAssessor": 0.82,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.86,
      "alt": "G",
      "chr": "chr2",
      "end": 29222258,
      "ref": "C",
      "CADD": 0.05,
      "REVEL": 0.88,
      "start": 29222295,
      "SIFT4G": 0.02,
      "GenBank": "NM_004304",
      "PROVEAN": 0.53,
      "variant": "I9454K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.62,
      "fathmm-MKL": 0.98,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.91],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.83
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.57],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.04],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.01
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.47, -0.44, -0.59],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.24,
            "FE_Bind_mean": -1.03
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.43, -0.41, -0.94],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.44, -1.06, -0.91],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.41,
            "FE_Bind_mean": -0.11
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.67,
      "Polyphen2_HDIV": 0.65,
      "Polyphen2_HVAR": 0.32,
      "MutationAssessor": 0.27,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.58,
      "alt": "A",
      "chr": "chr2",
      "end": 29222239,
      "ref": "A",
      "CADD": 0.56,
      "REVEL": 0.05,
      "start": 29222092,
      "SIFT4G": 0.79,
      "GenBank": "NM_004304",
      "PROVEAN": 0.42,
      "variant": "B8093A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.56,
      "fathmm-MKL": 0.79,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.16],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.25
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.07],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.35
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.65],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.23
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.89, -0.41, -0.78],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.78,
            "FE_Bind_mean": -0.81
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.56, -0.36, -0.71],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.29,
            "FE_Bind_mean": -0.82
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.81, -0.71, -0.46],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.59,
            "FE_Bind_mean": -0.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.01,
      "Polyphen2_HDIV": 0.19,
      "Polyphen2_HVAR": 0.26,
      "MutationAssessor": 0.92,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.02,
      "alt": "G",
      "chr": "chr2",
      "end": 29222111,
      "ref": "G",
      "CADD": 0.24,
      "REVEL": 0.86,
      "start": 29222496,
      "SIFT4G": 0.65,
      "GenBank": "NM_004304",
      "PROVEAN": 0.74,
      "variant": "C7516A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.86,
      "fathmm-MKL": 0.78,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.66],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.19],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.51
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.07],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.07
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.51, -0.35, -0.84],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.73,
            "FE_Bind_mean": -0.33
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.68, -0.01, -0.04],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.46,
            "FE_Bind_mean": -0.71
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.54, -0.52, -0.99],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.75,
            "FE_Bind_mean": -0.63
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.69,
      "Polyphen2_HDIV": 0.83,
      "Polyphen2_HVAR": 0.75,
      "MutationAssessor": 0.21,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.14,
      "alt": "T",
      "chr": "chr2",
      "end": 29222359,
      "ref": "C",
      "CADD": 0.28,
      "REVEL": 0.48,
      "start": 29222016,
      "SIFT4G": 0.73,
      "GenBank": "NM_004304",
      "PROVEAN": 0.58,
      "variant": "I6983A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.18,
      "fathmm-MKL": 0.84,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.05],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.66],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.99
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.52],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.57
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.68, -0.01, -1.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.32,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.98, -0.49, -0.76],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.58,
            "FE_Bind_mean": -1.14
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.75, -1.15, -0.48],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.35,
            "FE_Bind_mean": -0.01
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.59,
      "Polyphen2_HDIV": 0.23,
      "Polyphen2_HVAR": 0.56,
      "MutationAssessor": 0.54,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.49,
      "alt": "T",
      "chr": "chr2",
      "end": 29222972,
      "ref": "G",
      "CADD": 0.98,
      "REVEL": 0.56,
      "start": 29222527,
      "SIFT4G": 0.08,
      "GenBank": "NM_004304",
      "PROVEAN": 0.27,
      "variant": "B9314R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.79,
      "fathmm-MKL": 0.79,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.93],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.96
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.12],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.87
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.22],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.25
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.06, -0.01, -1.17],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.26,
            "FE_Bind_mean": -0.98
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.17, -0.39, -1.19],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.84,
            "FE_Bind_mean": -0.27
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.85, -0.17, -0.05],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.86,
            "FE_Bind_mean": -0.12
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.97,
      "Polyphen2_HDIV": 0.19,
      "Polyphen2_HVAR": 0.68,
      "MutationAssessor": 0.55,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.01,
      "alt": "A",
      "chr": "chr2",
      "end": 29222548,
      "ref": "A",
      "CADD": 0.19,
      "REVEL": 0.96,
      "start": 29222224,
      "SIFT4G": 0.42,
      "GenBank": "NM_004304",
      "PROVEAN": 0.22,
      "variant": "Q5382E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.21,
      "fathmm-MKL": 0.68,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.02],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.12
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.29],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.99],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.19, -0.94, -0.48],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.75,
            "FE_Bind_mean": -1.19
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.11, -0.07, -0.99],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.55,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.09, -0.79, -0.68],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.64,
            "FE_Bind_mean": -0.85
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.37,
      "Polyphen2_HDIV": 0.98,
      "Polyphen2_HVAR": 0.04,
      "MutationAssessor": 0.73,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.06,
      "alt": "G",
      "chr": "chr2",
      "end": 29222179,
      "ref": "A",
      "CADD": 0.12,
      "REVEL": 0.99,
      "start": 29222440,
      "SIFT4G": 0.03,
      "GenBank": "NM_004304",
      "PROVEAN": 0.31,
      "variant": "B8701A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.25,
      "fathmm-MKL": 0.84,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.17],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.15
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.48],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.22
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.18],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.05
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.82, -0.86, -0.16],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.53,
            "FE_Bind_mean": -1.14
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.27, -0.29, -0.92],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.11,
            "FE_Bind_mean": -0.32
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.08, -0.21, -1.01],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.85,
            "FE_Bind_mean": -1.07
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.51,
      "Polyphen2_HDIV": 0.07,
      "Polyphen2_HVAR": 0.07,
      "MutationAssessor": 0.91,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.36,
      "alt": "A",
      "chr": "chr2",
      "end": 29222277,
      "ref": "C",
      "CADD": 0.97,
      "REVEL": 0.24,
      "start": 29222385,
      "SIFT4G": 0.15,
      "GenBank": "NM_004304",
      "PROVEAN": 0.01,
      "variant": "A4868K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.19,
      "fathmm-MKL": 0.73,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.46],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.46
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.46],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.56
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.32],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.26
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.05, -0.07, -0.32],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -1.02
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.64, -0.12, -0.52],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.55,
            "FE_Bind_mean": -0.99
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.13, -0.75, -0.71],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -0.53
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.29,
      "Polyphen2_HDIV": 0.65,
      "Polyphen2_HVAR": 0.52,
      "MutationAssessor": 0.18,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.05,
      "alt": "G",
      "chr": "chr2",
      "end": 29222020,
      "ref": "A",
      "CADD": 0.64,
      "REVEL": 0.58,
      "start": 29222075,
      "SIFT4G": 0.99,
      "GenBank": "NM_004304",
      "PROVEAN": 0.36,
      "variant": "Q9357R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.73,
      "fathmm-MKL": 0.94,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.88],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.17
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.38],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.06
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.83],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.09
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.13, -0.46, -1.08],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.03,
            "FE_Bind_mean": -1.17
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.39, -0.61, -0.31],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.01,
            "FE_Bind_mean": -0.15
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.42, -0.62, -0.82],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -0.64
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.43,
      "Polyphen2_HDIV": 0.54,
      "Polyphen2_HVAR": 0.61,
      "MutationAssessor": 0.01,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.17,
      "alt": "G",
      "chr": "chr2",
      "end": 29222169,
      "ref": "G",
      "CADD": 0.23,
      "REVEL": 0.57,
      "start": 29222386,
      "SIFT4G": 0.67,
      "GenBank": "NM_004304",
      "PROVEAN": 0.97,
      "variant": "C2694M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.02,
      "fathmm-MKL": 0.69,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.75],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.66
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.71],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.93
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.03],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.81
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.69, -0.58, -0.09],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.57,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.03, -0.28, -1.12],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.81,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.47, -0.87, -0.18],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.07,
            "FE_Bind_mean": -0.81
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.66,
      "Polyphen2_HDIV": 0.65,
      "Polyphen2_HVAR": 0.94,
      "MutationAssessor": 0.94,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.84,
      "alt": "G",
      "chr": "chr2",
      "end": 29222655,
      "ref": "A",
      "CADD": 0.33,
      "REVEL": 0.41,
      "start": 29222694,
      "SIFT4G": 0.18,
      "GenBank": "NM_004304",
      "PROVEAN": 0.78,
      "variant": "P7998E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.37,
      "fathmm-MKL": 0.91,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.82],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.58
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.19],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.23
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.37],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.98
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.13, -0.93, -0.52],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.12,
            "FE_Bind_mean": -0.82
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.59, -0.94, -0.85],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.62,
            "FE_Bind_mean": -0.64
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.59, -0.25, -1.07],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.11,
            "FE_Bind_mean": -1.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.96,
      "Polyphen2_HDIV": 0.84,
      "Polyphen2_HVAR": 0.92,
      "MutationAssessor": 0.15,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.49,
      "alt": "T",
      "chr": "chr2",
      "end": 29222273,
      "ref": "A",
      "CADD": 0.58,
      "REVEL": 0.93,
      "start": 29222547,
      "SIFT4G": 0.47,
      "GenBank": "NM_004304",
      "PROVEAN": 0.98,
      "variant": "C3270A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.42,
      "fathmm-MKL": 0.65,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.33],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.48],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.69
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.88],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.48
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.26, -1.18, -0.58],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.37,
            "FE_Bind_mean": -0.27
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.83, -0.19, -0.34],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.44,
            "FE_Bind_mean": -0.29
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.43, -1.15, -0.48],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.45,
            "FE_Bind_mean": -0.14
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.77,
      "Polyphen2_HDIV": 0.47,
      "Polyphen2_HVAR": 0.43,
      "MutationAssessor": 0.86,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.56,
      "alt": "T",
      "chr": "chr2",
      "end": 29222367,
      "ref": "C",
      "CADD": 0.57,
      "REVEL": 0.06,
      "start": 29222465,
      "SIFT4G": 0.05,
      "GenBank": "NM_004304",
      "PROVEAN": 0.62,
      "variant": "I2415K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.46,
      "fathmm-MKL": 0.99,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.08],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.97
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.17],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.04
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.71],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.58
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.16, -1.04, -0.97],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.36,
            "FE_Bind_mean": -1.13
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.52, -0.52, -1.11],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -0.42
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.18, -0.09, -0.36],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.73,
            "FE_Bind_mean": -0.79
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.58,
      "Polyphen2_HDIV": 0.55,
      "Polyphen2_HVAR": 0.92,
      "MutationAssessor": 0.36,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.67,
      "alt": "G",
      "chr": "chr2",
      "end": 29222296,
      "ref": "C",
      "CADD": 0.99,
      "REVEL": 0.45,
      "start": 29222746,
      "SIFT4G": 0.39,
      "GenBank": "NM_004304",
      "PROVEAN": 0.05,
      "variant": "A4608M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.36,
      "fathmm-MKL": 0.78,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.05],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.06
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.18],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.54
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.07
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.02, -0.32, -0.74],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.26,
            "FE_Bind_mean": -0.33
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.18, -0.45, -0.84],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.21,
            "FE_Bind_mean": -0.43
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.58, -0.48, -0.02],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.79,
            "FE_Bind_mean": -0.61
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.46,
      "Polyphen2_HDIV": 0.41,
      "Polyphen2_HVAR": 0.07,
      "MutationAssessor": 0.65,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.23,
      "alt": "T",
      "chr": "chr2",
      "end": 29222370,
      "ref": "C",
      "CADD": 0.58,
      "REVEL": 0.16,
      "start": 29222135,
      "SIFT4G": 0.51,
      "GenBank": "NM_004304",
      "PROVEAN": 0.49,
      "variant": "B4195A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.14,
      "fathmm-MKL": 0.62,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.11],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.03],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.77
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.82],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.65
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.02, -0.75, -0.39],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.57,
            "FE_Bind_mean": -0.03
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.82, -0.26, -0.99],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -0.82
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.15, -1.01, -0.19],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.19,
            "FE_Bind_mean": -0.03
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.51,
      "Polyphen2_HDIV": 0.21,
      "Polyphen2_HVAR": 0.02,
      "MutationAssessor": 0.98,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.49,
      "alt": "C",
      "chr": "chr2",
      "end": 29222190,
      "ref": "C",
      "CADD": 0.66,
      "REVEL": 0.89,
      "start": 29222129,
      "SIFT4G": 0.56,
      "GenBank": "NM_004304",
      "PROVEAN": 0.64,
      "variant": "B1784E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.97,
      "fathmm-MKL": 0.87,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.12],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.37
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.66],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.28],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.82
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.11, -0.18, -0.32],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.79,
            "FE_Bind_mean": -0.06
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.62, -0.95, -0.19],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.68,
            "FE_Bind_mean": -1.04
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.89, -0.49, -0.27],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.72,
            "FE_Bind_mean": -0.61
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.81,
      "Polyphen2_HDIV": 0.64,
      "Polyphen2_HVAR": 0.28,
      "MutationAssessor": 0.26,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.87,
      "alt": "G",
      "chr": "chr2",
      "end": 29222422,
      "ref": "A",
      "CADD": 0.24,
      "REVEL": 0.51,
      "start": 29222854,
      "SIFT4G": 0.68,
      "GenBank": "NM_004304",
      "PROVEAN": 0.12,
      "variant": "Q8452R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.07,
      "fathmm-MKL": 0.89,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.61],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.43
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.15],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.64
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.16],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.62
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.63, -0.55, -1.11],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.65,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.42, -1.18, -0.12],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.11,
            "FE_Bind_mean": -1.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.19, -0.95, -1.17],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.58,
            "FE_Bind_mean": -0.61
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.27,
      "Polyphen2_HDIV": 0.12,
      "Polyphen2_HVAR": 0.87,
      "MutationAssessor": 0.58,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.25,
      "alt": "A",
      "chr": "chr2",
      "end": 29222869,
      "ref": "G",
      "CADD": 0.22,
      "REVEL": 0.72,
      "start": 29222026,
      "SIFT4G": 0.58,
      "GenBank": "NM_004304",
      "PROVEAN": 0.88,
      "variant": "Q9941V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.28,
      "fathmm-MKL": 0.95,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.13],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.35
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.93],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.98
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.37],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.05
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.62, -0.36, -0.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.52,
            "FE_Bind_mean": -0.94
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.53, -0.82, -0.61],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.19,
            "FE_Bind_mean": -0.12
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.37, -0.35, -0.86],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.65,
            "FE_Bind_mean": -1.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.56,
      "Polyphen2_HDIV": 0.15,
      "Polyphen2_HVAR": 0.61,
      "MutationAssessor": 0.06,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.53,
      "alt": "C",
      "chr": "chr2",
      "end": 29222004,
      "ref": "C",
      "CADD": 0.23,
      "REVEL": 0.55,
      "start": 29222457,
      "SIFT4G": 0.88,
      "GenBank": "NM_004304",
      "PROVEAN": 0.29,
      "variant": "A1510M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.31,
      "fathmm-MKL": 0.65,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.29],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.72
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.24],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.16
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.86],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.73
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.85, -1.08, -0.34],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.47,
            "FE_Bind_mean": -0.94
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.96, -1.01, -0.44],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.05,
            "FE_Bind_mean": -1.18
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.95, -0.84, -0.91],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.78,
            "FE_Bind_mean": -0.56
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.49,
      "Polyphen2_HDIV": 0.12,
      "Polyphen2_HVAR": 0.09,
      "MutationAssessor": 0.55,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.07,
      "alt": "A",
      "chr": "chr2",
      "end": 29222982,
      "ref": "G",
      "CADD": 0.53,
      "REVEL": 0.31,
      "start": 29222947,
      "SIFT4G": 0.57,
      "GenBank": "NM_004304",
      "PROVEAN": 0.48,
      "variant": "B8238A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.99,
      "fathmm-MKL": 0.74,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.04
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.73],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.38
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.54],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.57
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.94, -0.22, -1.12],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.09,
            "FE_Bind_mean": -0.52
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.09, -0.38, -0.98],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.54,
            "FE_Bind_mean": -0.02
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.25, -0.18, -0.93],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.15,
            "FE_Bind_mean": -0.22
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.27,
      "Polyphen2_HDIV": 0.52,
      "Polyphen2_HVAR": 0.25,
      "MutationAssessor": 0.76,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.05,
      "alt": "T",
      "chr": "chr2",
      "end": 29222180,
      "ref": "C",
      "CADD": 0.78,
      "REVEL": 0.57,
      "start": 29222413,
      "SIFT4G": 0.43,
      "GenBank": "NM_004304",
      "PROVEAN": 0.61,
      "variant": "Q1281K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.09,
      "fathmm-MKL": 0.93,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.03],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.16],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.85
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.22],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.69
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.04, -0.47, -1.18],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.51,
            "FE_Bind_mean": -0.71
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.84, -0.76, -1.12],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.26,
            "FE_Bind_mean": -0.53
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.32, -0.89, -0.14],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -1.09
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.52,
      "Polyphen2_HDIV": 0.14,
      "Polyphen2_HVAR": 0.18,
      "MutationAssessor": 0.69,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.17,
      "alt": "G",
      "chr": "chr2",
      "end": 29222681,
      "ref": "C",
      "CADD": 0.27,
      "REVEL": 0.53,
      "start": 29222730,
      "SIFT4G": 0.89,
      "GenBank": "NM_004304",
      "PROVEAN": 0.12,
      "variant": "Q9216A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.65,
      "fathmm-MKL": 0.99,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.19],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.52
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.35],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.47
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.49
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.73, -0.76, -0.66],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.34
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.48, -0.04, -0.06],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.84,
            "FE_Bind_mean": -0.58
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.53, -1.02, -1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.76,
            "FE_Bind_mean": -1.15
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.94,
      "Polyphen2_HDIV": 0.15,
      "Polyphen2_HVAR": 0.49,
      "MutationAssessor": 0.44,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.59,
      "alt": "T",
      "chr": "chr2",
      "end": 29222239,
      "ref": "G",
      "CADD": 0.91,
      "REVEL": 0.24,
      "start": 29222665,
      "SIFT4G": 0.71,
      "GenBank": "NM_004304",
      "PROVEAN": 0.89,
      "variant": "A4979E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.69,
      "fathmm-MKL": 0.96,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.44],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.67
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.35],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.93
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.17],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.88
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.45, -0.69, -0.79],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.81,
            "FE_Bind_mean": -0.68
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.93, -0.53, -0.39],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.86,
            "FE_Bind_mean": -0.23
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.21, -0.18, -0.87],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.66,
            "FE_Bind_mean": -0.72
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.26,
      "Polyphen2_HDIV": 0.52,
      "Polyphen2_HVAR": 0.37,
      "MutationAssessor": 0.81,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.19,
      "alt": "G",
      "chr": "chr2",
      "end": 29222853,
      "ref": "G",
      "CADD": 0.03,
      "REVEL": 0.01,
      "start": 29222617,
      "SIFT4G": 0.59,
      "GenBank": "NM_004304",
      "PROVEAN": 0.15,
      "variant": "P9882A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.43,
      "fathmm-MKL": 0.73,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.63],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.04
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.58],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.16
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.58],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.18
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.13, -0.43, -0.69],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.31,
            "FE_Bind_mean": -0.68
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.38, -0.23, -0.31],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -1.13
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.29, -0.16, -0.47],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.58,
            "FE_Bind_mean": -0.09
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.89,
      "Polyphen2_HDIV": 0.79,
      "Polyphen2_HVAR": 0.38,
      "MutationAssessor": 0.96,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.49,
      "alt": "C",
      "chr": "chr2",
      "end": 29222743,
      "ref": "C",
      "CADD": 0.31,
      "REVEL": 0.19,
      "start": 29222533,
      "SIFT4G": 0.61,
      "GenBank": "NM_004304",
      "PROVEAN": 0.18,
      "variant": "I1823E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.79,
      "fathmm-MKL": 0.91,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.16],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.32
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.03],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.03],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.81
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.31, -0.28, -0.29],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.09,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.81, -0.81, -0.18],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.79,
            "FE_Bind_mean": -1.12
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.92, -0.95, -0.64],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -0.87
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.81,
      "Polyphen2_HDIV": 0.92,
      "Polyphen2_HVAR": 0.16,
      "MutationAssessor": 0.23,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.18,
      "alt": "A",
      "chr": "chr2",
      "end": 29222509,
      "ref": "A",
      "CADD": 0.75,
      "REVEL": 0.04,
      "start": 29222620,
      "SIFT4G": 0.48,
      "GenBank": "NM_004304",
      "PROVEAN": 0.96,
      "variant": "A9082M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.06,
      "fathmm-MKL": 0.84,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.88],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.09
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.71],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.31
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.17],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.71
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.18, -0.03, -0.67],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.14,
            "FE_Bind_mean": -0.56
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.13, -1.13, -0.79],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.63,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.34, -1.14, -1.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -0.76
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.49,
      "Polyphen2_HDIV": 0.26,
      "Polyphen2_HVAR": 0.34,
      "MutationAssessor": 0.15,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.94,
      "alt": "A",
      "chr": "chr2",
      "end": 29222275,
      "ref": "C",
      "CADD": 0.78,
      "REVEL": 0.26,
      "start": 29222573,
      "SIFT4G": 0.98,
      "GenBank": "NM_004304",
      "PROVEAN": 0.28,
      "variant": "A5431M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.01,
      "fathmm-MKL": 0.96,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.95],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.97
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.37],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.85
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.39],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.25
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.32, -0.94, -0.59],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.58,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.12, -0.84, -0.91],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.47,
            "FE_Bind_mean": -0.59
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.13, -0.33, -0.45],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.42,
            "FE_Bind_mean": -0.46
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.07,
      "Polyphen2_HDIV": 0.53,
      "Polyphen2_HVAR": 0.65,
      "MutationAssessor": 0.84,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.93,
      "alt": "C",
      "chr": "chr2",
      "end": 29222752,
      "ref": "G",
      "CADD": 0.38,
      "REVEL": 0.61,
      "start": 29222298,
      "SIFT4G": 0.42,
      "GenBank": "NM_004304",
      "PROVEAN": 0.89,
      "variant": "P4870R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.82,
      "fathmm-MKL": 0.88,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.16],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.14
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.02],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.03
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.85],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.57
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.18, -1.02, -0.86],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.04,
            "FE_Bind_mean": -1.15
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.51, -1.19, -0.17],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.45,
            "FE_Bind_mean": -0.26
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.41, -0.36, -0.24],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.35,
            "FE_Bind_mean": -1.15
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.27,
      "Polyphen2_HDIV": 0.33,
      "Polyphen2_HVAR": 0.89,
      "MutationAssessor": 0.22,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.87,
      "alt": "C",
      "chr": "chr2",
      "end": 29222084,
      "ref": "G",
      "CADD": 0.85,
      "REVEL": 0.63,
      "start": 29222248,
      "SIFT4G": 0.83,
      "GenBank": "NM_004304",
      "PROVEAN": 0.09,
      "variant": "C8010M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.35,
      "fathmm-MKL": 0.69,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.57],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.88
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.87],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.06
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.17],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.19, -1.17, -0.51],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.42,
            "FE_Bind_mean": -0.34
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.23, -0.99, -0.89],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.55,
            "FE_Bind_mean": -0.96
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.43, -0.17, -0.07],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.43,
            "FE_Bind_mean": -0.05
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.83,
      "Polyphen2_HDIV": 0.75,
      "Polyphen2_HVAR": 0.65,
      "MutationAssessor": 0.08,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.24,
      "alt": "A",
      "chr": "chr2",
      "end": 29222266,
      "ref": "G",
      "CADD": 0.88,
      "REVEL": 0.98,
      "start": 29222084,
      "SIFT4G": 0.23,
      "GenBank": "NM_004304",
      "PROVEAN": 0.05,
      "variant": "L2848K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.33,
      "fathmm-MKL": 0.74,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.95],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.24
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.27],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.42],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.43
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.27, -0.86, -0.71],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.68,
            "FE_Bind_mean": -0.89
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.04, -0.47, -0.18],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.27,
            "FE_Bind_mean": -0.94
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.37, -0.83, -0.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.03,
            "FE_Bind_mean": -1.11
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.87,
      "Polyphen2_HDIV": 0.79,
      "Polyphen2_HVAR": 0.14,
      "MutationAssessor": 0.83,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.89,
      "alt": "G",
      "chr": "chr2",
      "end": 29222040,
      "ref": "C",
      "CADD": 0.47,
      "REVEL": 0.89,
      "start": 29222346,
      "SIFT4G": 0.66,
      "GenBank": "NM_004304",
      "PROVEAN": 0.78,
      "variant": "B1031M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.38,
      "fathmm-MKL": 0.88,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.18],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.03
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.82],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.12
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.13],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.82
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.16, -0.86, -0.61],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.16,
            "FE_Bind_mean": -0.38
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.03, -0.56, -1.14],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.26,
            "FE_Bind_mean": -1.11
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.58, -1.01, -1.01],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.69,
            "FE_Bind_mean": -1.05
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.73,
      "Polyphen2_HDIV": 0.14,
      "Polyphen2_HVAR": 0.32,
      "MutationAssessor": 0.21,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.34,
      "alt": "C",
      "chr": "chr2",
      "end": 29222941,
      "ref": "G",
      "CADD": 0.54,
      "REVEL": 0.52,
      "start": 29222651,
      "SIFT4G": 0.76,
      "GenBank": "NM_004304",
      "PROVEAN": 0.28,
      "variant": "B6317E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.06,
      "fathmm-MKL": 0.75,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.56],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.53
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.53],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.47
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.28
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.45, -1.18, -0.32],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -0.81
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.18, -0.91, -1.13],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.68,
            "FE_Bind_mean": -0.98
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.65, -0.69, -1.12],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.47,
            "FE_Bind_mean": -0.72
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.96,
      "Polyphen2_HDIV": 0.35,
      "Polyphen2_HVAR": 0.99,
      "MutationAssessor": 0.48,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.37,
      "alt": "C",
      "chr": "chr2",
      "end": 29222494,
      "ref": "G",
      "CADD": 0.14,
      "REVEL": 0.83,
      "start": 29222034,
      "SIFT4G": 0.51,
      "GenBank": "NM_004304",
      "PROVEAN": 0.61,
      "variant": "B5816A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.57,
      "fathmm-MKL": 0.86,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.03],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.26
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.05],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.91
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.86],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.56
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.03, -1.17, -0.08],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -1.12
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.14, -0.53, -0.16],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.79,
            "FE_Bind_mean": -0.89
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.93, -0.82, -0.01],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.42,
            "FE_Bind_mean": -0.28
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.67,
      "Polyphen2_HDIV": 0.62,
      "Polyphen2_HVAR": 0.08,
      "MutationAssessor": 0.55,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.01,
      "alt": "C",
      "chr": "chr2",
      "end": 29222634,
      "ref": "A",
      "CADD": 0.72,
      "REVEL": 0.89,
      "start": 29222148,
      "SIFT4G": 0.93,
      "GenBank": "NM_004304",
      "PROVEAN": 0.76,
      "variant": "C4370A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.83,
      "fathmm-MKL": 0.96,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.53],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.85],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.68
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.96
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.29, -0.44, -0.19],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.81,
            "FE_Bind_mean": -0.55
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.15, -0.62, -0.89],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.79,
            "FE_Bind_mean": -0.53
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.86, -0.89, -0.64],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -0.71
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.18,
      "Polyphen2_HDIV": 0.96,
      "Polyphen2_HVAR": 0.89,
      "MutationAssessor": 0.52,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.42,
      "alt": "G",
      "chr": "chr2",
      "end": 29222350,
      "ref": "C",
      "CADD": 0.61,
      "REVEL": 0.02,
      "start": 29222743,
      "SIFT4G": 0.84,
      "GenBank": "NM_004304",
      "PROVEAN": 0.95,
      "variant": "B4150R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.85,
      "fathmm-MKL": 0.96,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.72],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.55
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.11],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.89
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.15],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.03
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.17, -1.17, -0.96],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.35,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.82, -0.21, -1.11],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.43,
            "FE_Bind_mean": -0.82
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.45, -0.64, -0.59],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.76,
            "FE_Bind_mean": -0.26
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.76,
      "Polyphen2_HDIV": 0.35,
      "Polyphen2_HVAR": 0.51,
      "MutationAssessor": 0.12,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.52,
      "alt": "C",
      "chr": "chr2",
      "end": 29222762,
      "ref": "A",
      "CADD": 0.55,
      "REVEL": 0.58,
      "start": 29222042,
      "SIFT4G": 0.67,
      "GenBank": "NM_004304",
      "PROVEAN": 0.36,
      "variant": "A3067R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.77,
      "fathmm-MKL": 0.68,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.12],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.72
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.88],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.39],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.78, -0.17, -0.41],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.62,
            "FE_Bind_mean": -0.38
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.08, -1.09, -0.54],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.82,
            "FE_Bind_mean": -0.57
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.39, -0.85, -0.68],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.79,
            "FE_Bind_mean": -0.43
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.78,
      "Polyphen2_HDIV": 0.11,
      "Polyphen2_HVAR": 0.39,
      "MutationAssessor": 0.07,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.73,
      "alt": "A",
      "chr": "chr2",
      "end": 29222763,
      "ref": "G",
      "CADD": 0.95,
      "REVEL": 0.68,
      "start": 29222055,
      "SIFT4G": 0.09,
      "GenBank": "NM_004304",
      "PROVEAN": 0.76,
      "variant": "Q8058V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.32,
      "fathmm-MKL": 0.64,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.17],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.56
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.03],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.83
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.17],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.87
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.76, -0.84, -1.14],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.09,
            "FE_Bind_mean": -0.84
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.88, -0.22, -0.85],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.01,
            "FE_Bind_mean": -0.41
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.12, -0.54, -0.57],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.76,
            "FE_Bind_mean": -0.09
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.24,
      "Polyphen2_HDIV": 0.86,
      "Polyphen2_HVAR": 0.89,
      "MutationAssessor": 0.86,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.77,
      "alt": "A",
      "chr": "chr2",
      "end": 29222424,
      "ref": "G",
      "CADD": 0.71,
      "REVEL": 0.44,
      "start": 29222277,
      "SIFT4G": 0.37,
      "GenBank": "NM_004304",
      "PROVEAN": 0.25,
      "variant": "C5562K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.24,
      "fathmm-MKL": 0.66,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.73],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.92],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.18
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.21],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.46
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.91, -0.75, -1.04],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.77,
            "FE_Bind_mean": -0.15
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.72, -0.41, -1.02],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.07,
            "FE_Bind_mean": -0.14
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.75, -0.46, -0.82],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.35,
            "FE_Bind_mean": -0.36
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.72,
      "Polyphen2_HDIV": 0.05,
      "Polyphen2_HVAR": 0.26,
      "MutationAssessor": 0.25,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.83,
      "alt": "C",
      "chr": "chr2",
      "end": 29222002,
      "ref": "G",
      "CADD": 0.99,
      "REVEL": 0.41,
      "start": 29222480,
      "SIFT4G": 0.77,
      "GenBank": "NM_004304",
      "PROVEAN": 0.27,
      "variant": "I8993A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.89,
      "fathmm-MKL": 0.89,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.85],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.13
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.85],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.69
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.76],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.16
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.85, -0.73, -0.62],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.31,
            "FE_Bind_mean": -1.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.68, -0.01, -0.16],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.06,
            "FE_Bind_mean": -1.19
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.44, -1.13, -0.04],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.21,
            "FE_Bind_mean": -0.26
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.82,
      "Polyphen2_HDIV": 0.34,
      "Polyphen2_HVAR": 0.73,
      "MutationAssessor": 0.24,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.28,
      "alt": "A",
      "chr": "chr2",
      "end": 29222606,
      "ref": "G",
      "CADD": 0.32,
      "REVEL": 0.38,
      "start": 29222627,
      "SIFT4G": 0.44,
      "GenBank": "NM_004304",
      "PROVEAN": 0.15,
      "variant": "P2391K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.48,
      "fathmm-MKL": 0.74,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.12],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.73
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.71],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.73
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.12
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.65, -0.08, -0.31],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.22,
            "FE_Bind_mean": -0.28
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.64, -0.44, -0.66],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.27,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.41, -0.51, -0.16],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.52,
            "FE_Bind_mean": -1.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.38,
      "Polyphen2_HDIV": 0.65,
      "Polyphen2_HVAR": 0.59,
      "MutationAssessor": 0.39,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.58,
      "alt": "G",
      "chr": "chr2",
      "end": 29222687,
      "ref": "G",
      "CADD": 0.19,
      "REVEL": 0.07,
      "start": 29222322,
      "SIFT4G": 0.96,
      "GenBank": "NM_004304",
      "PROVEAN": 0.78,
      "variant": "P1876R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.82,
      "fathmm-MKL": 0.96,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.53],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.02],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.16],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.41
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.32, -0.62, -0.87],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.17,
            "FE_Bind_mean": -0.62
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.77, -0.77, -0.49],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.84,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.29, -0.96, -0.65],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.37,
            "FE_Bind_mean": -0.53
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.05,
      "Polyphen2_HDIV": 0.09,
      "Polyphen2_HVAR": 0.24,
      "MutationAssessor": 0.32,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.03,
      "alt": "G",
      "chr": "chr2",
      "end": 29222074,
      "ref": "C",
      "CADD": 0.24,
      "REVEL": 0.03,
      "start": 29222488,
      "SIFT4G": 0.08,
      "GenBank": "NM_004304",
      "PROVEAN": 0.38,
      "variant": "L6127E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.76,
      "fathmm-MKL": 0.64,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.89],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.73
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.62],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.78],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.06
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.01, -0.83, -0.54],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.43,
            "FE_Bind_mean": -0.41
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.95, -0.33, -0.96],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.24,
            "FE_Bind_mean": -0.22
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.63, -0.44, -1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.81,
            "FE_Bind_mean": -0.89
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.49,
      "Polyphen2_HDIV": 0.02,
      "Polyphen2_HVAR": 0.76,
      "MutationAssessor": 0.92,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.69,
      "alt": "C",
      "chr": "chr2",
      "end": 29222025,
      "ref": "A",
      "CADD": 0.84,
      "REVEL": 0.23,
      "start": 29222695,
      "SIFT4G": 0.94,
      "GenBank": "NM_004304",
      "PROVEAN": 0.83,
      "variant": "B9990R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.56,
      "fathmm-MKL": 0.84,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.78],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.57
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.46],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.78
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.14],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.07
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.58, -0.86, -0.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.25,
            "FE_Bind_mean": -0.15
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.15, -0.57, -0.32],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.46,
            "FE_Bind_mean": -0.51
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.46, -0.49, -0.05],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -0.75
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.43,
      "Polyphen2_HDIV": 0.15,
      "Polyphen2_HVAR": 0.49,
      "MutationAssessor": 0.26,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.87,
      "alt": "C",
      "chr": "chr2",
      "end": 29222042,
      "ref": "G",
      "CADD": 0.91,
      "REVEL": 0.96,
      "start": 29222251,
      "SIFT4G": 0.44,
      "GenBank": "NM_004304",
      "PROVEAN": 0.36,
      "variant": "P4030V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.59,
      "fathmm-MKL": 0.92,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.32],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.32],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.68],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.06
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.88, -0.53, -0.38],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.04,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.33, -0.26, -0.62],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.39,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.26, -0.94, -0.74],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.76,
            "FE_Bind_mean": -0.16
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.14,
      "Polyphen2_HDIV": 0.92,
      "Polyphen2_HVAR": 0.73,
      "MutationAssessor": 0.25,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.91,
      "alt": "G",
      "chr": "chr2",
      "end": 29222832,
      "ref": "A",
      "CADD": 0.59,
      "REVEL": 0.11,
      "start": 29222799,
      "SIFT4G": 0.86,
      "GenBank": "NM_004304",
      "PROVEAN": 0.54,
      "variant": "A6836V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.09,
      "fathmm-MKL": 0.82,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.43],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.44],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.51],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.16, -0.13, -0.97],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.39,
            "FE_Bind_mean": -1.07
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.99, -1.19, -0.25],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.88,
            "FE_Bind_mean": -1.13
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.26, -0.48, -0.95],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.16,
            "FE_Bind_mean": -1.12
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.06,
      "Polyphen2_HDIV": 0.27,
      "Polyphen2_HVAR": 0.22,
      "MutationAssessor": 0.85,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.72,
      "alt": "T",
      "chr": "chr2",
      "end": 29222735,
      "ref": "A",
      "CADD": 0.23,
      "REVEL": 0.13,
      "start": 29222836,
      "SIFT4G": 0.55,
      "GenBank": "NM_004304",
      "PROVEAN": 0.74,
      "variant": "C3279A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.78,
      "fathmm-MKL": 0.94,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.17],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.62
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.11],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.84
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.54],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.49
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.13, -0.97, -1.14],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.62,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.15, -0.11, -0.54],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.16,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.15, -0.04, -0.39],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.31,
            "FE_Bind_mean": -1.12
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.66,
      "Polyphen2_HDIV": 0.91,
      "Polyphen2_HVAR": 0.78,
      "MutationAssessor": 0.16,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.33,
      "alt": "A",
      "chr": "chr2",
      "end": 29222253,
      "ref": "A",
      "CADD": 0.17,
      "REVEL": 0.74,
      "start": 29222689,
      "SIFT4G": 0.52,
      "GenBank": "NM_004304",
      "PROVEAN": 0.72,
      "variant": "I4114K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.81,
      "fathmm-MKL": 0.75,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.41],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.91],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.54
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.27
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.32, -0.34, -0.42],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.45,
            "FE_Bind_mean": -0.25
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.25, -0.45, -0.27],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.84,
            "FE_Bind_mean": -0.27
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.29, -0.77, -0.88],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.73,
            "FE_Bind_mean": -0.84
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.34,
      "Polyphen2_HDIV": 0.56,
      "Polyphen2_HVAR": 0.46,
      "MutationAssessor": 0.13,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.45,
      "alt": "T",
      "chr": "chr2",
      "end": 29222532,
      "ref": "C",
      "CADD": 0.91,
      "REVEL": 0.87,
      "start": 29222400,
      "SIFT4G": 0.63,
      "GenBank": "NM_004304",
      "PROVEAN": 0.06,
      "variant": "Q4515A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.63,
      "fathmm-MKL": 0.83,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.91],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.48
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.47],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.64
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.77],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.47
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.07, -0.19, -0.21],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.25,
            "FE_Bind_mean": -0.62
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.71, -1.14, -0.24],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.05,
            "FE_Bind_mean": -0.25
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.27, -1.11, -0.97],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.34,
            "FE_Bind_mean": -0.02
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.27,
      "Polyphen2_HDIV": 0.31,
      "Polyphen2_HVAR": 0.19,
      "MutationAssessor": 0.83,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.03,
      "alt": "G",
      "chr": "chr2",
      "end": 29222377,
      "ref": "A",
      "CADD": 0.08,
      "REVEL": 0.39,
      "start": 29222654,
      "SIFT4G": 0.89,
      "GenBank": "NM_004304",
      "PROVEAN": 0.44,
      "variant": "Q8063R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.85,
      "fathmm-MKL": 0.94,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.01],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.89],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.62],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.03
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.01, -0.85, -0.55],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.14,
            "FE_Bind_mean": -0.63
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.91, -0.28, -1.05],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.49,
            "FE_Bind_mean": -0.03
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.36, -0.28, -0.92],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.07,
            "FE_Bind_mean": -0.44
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.12,
      "Polyphen2_HDIV": 0.06,
      "Polyphen2_HVAR": 0.57,
      "MutationAssessor": 0.05,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.65,
      "alt": "G",
      "chr": "chr2",
      "end": 29222025,
      "ref": "G",
      "CADD": 0.97,
      "REVEL": 0.63,
      "start": 29222366,
      "SIFT4G": 0.74,
      "GenBank": "NM_004304",
      "PROVEAN": 0.36,
      "variant": "I9436E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.97,
      "fathmm-MKL": 0.88,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.59],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.33
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.07],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.33
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.75],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.67
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.69, -0.69, -0.37],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.24, -0.62, -0.29],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -0.55
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.69, -0.88, -0.02],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.12
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.74,
      "Polyphen2_HDIV": 0.42,
      "Polyphen2_HVAR": 0.48,
      "MutationAssessor": 0.49,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.69,
      "alt": "T",
      "chr": "chr2",
      "end": 29222252,
      "ref": "A",
      "CADD": 0.38,
      "REVEL": 0.32,
      "start": 29222328,
      "SIFT4G": 0.16,
      "GenBank": "NM_004304",
      "PROVEAN": 0.32,
      "variant": "P4501A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.44,
      "fathmm-MKL": 0.71,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.05],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.42],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.64
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.16
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.09, -0.48, -1.11],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.64,
            "FE_Bind_mean": -0.28
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.92, -0.36, -0.23],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.54,
            "FE_Bind_mean": -0.24
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.07, -0.61, -0.21],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -1.02
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.51,
      "Polyphen2_HDIV": 0.73,
      "Polyphen2_HVAR": 0.49,
      "MutationAssessor": 0.62,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.02,
      "alt": "A",
      "chr": "chr2",
      "end": 29222289,
      "ref": "A",
      "CADD": 0.93,
      "REVEL": 0.11,
      "start": 29222295,
      "SIFT4G": 0.04,
      "GenBank": "NM_004304",
      "PROVEAN": 0.03,
      "variant": "P9287E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.99,
      "fathmm-MKL": 0.98,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.97],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.82],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.18
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.74],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.12
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.42, -0.25, -0.81],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.12,
            "FE_Bind_mean": -0.96
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.07, -0.57, -0.78],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.65,
            "FE_Bind_mean": -0.83
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.03, -0.04, -0.29],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.64,
            "FE_Bind_mean": -0.07
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.28,
      "Polyphen2_HDIV": 0.06,
      "Polyphen2_HVAR": 0.87,
      "MutationAssessor": 0.68,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.46,
      "alt": "T",
      "chr": "chr2",
      "end": 29222027,
      "ref": "C",
      "CADD": 0.12,
      "REVEL": 0.81,
      "start": 29222090,
      "SIFT4G": 0.27,
      "GenBank": "NM_004304",
      "PROVEAN": 0.31,
      "variant": "I1498A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.62,
      "fathmm-MKL": 0.86,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.11
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.33],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.98
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.07],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.31
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.96, -0.67, -0.74],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.55,
            "FE_Bind_mean": -0.28
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.65, -0.26, -0.01],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.56,
            "FE_Bind_mean": -0.43
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.11, -0.35, -0.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.78,
            "FE_Bind_mean": -0.85
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.96,
      "Polyphen2_HDIV": 0.35,
      "Polyphen2_HVAR": 0.59,
      "MutationAssessor": 0.92,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.22,
      "alt": "A",
      "chr": "chr2",
      "end": 29222018,
      "ref": "A",
      "CADD": 0.28,
      "REVEL": 0.81,
      "start": 29222273,
      "SIFT4G": 0.85,
      "GenBank": "NM_004304",
      "PROVEAN": 0.81,
      "variant": "L4406M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.53,
      "fathmm-MKL": 0.82,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.68],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.82
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.95],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.19
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.06],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.53
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.14, -0.28, -0.75],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.34,
            "FE_Bind_mean": -0.02
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.57, -0.65, -0.58],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.84,
            "FE_Bind_mean": -0.12
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.53, -0.18, -0.21],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.76,
            "FE_Bind_mean": -0.69
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.78,
      "Polyphen2_HDIV": 0.23,
      "Polyphen2_HVAR": 0.83,
      "MutationAssessor": 0.68,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.77,
      "alt": "A",
      "chr": "chr2",
      "end": 29222815,
      "ref": "A",
      "CADD": 0.64,
      "REVEL": 0.11,
      "start": 29222980,
      "SIFT4G": 0.38,
      "GenBank": "NM_004304",
      "PROVEAN": 0.61,
      "variant": "Q1620E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.22,
      "fathmm-MKL": 0.76,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.69
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.14],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.36],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.19
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.34, -0.09, -0.47],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.38,
            "FE_Bind_mean": -0.59
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.54, -1.04, -0.18],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.25,
            "FE_Bind_mean": -0.85
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.78, -1.09, -0.25],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.87,
            "FE_Bind_mean": -0.75
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.66,
      "Polyphen2_HDIV": 0.51,
      "Polyphen2_HVAR": 0.06,
      "MutationAssessor": 0.95,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.43,
      "alt": "G",
      "chr": "chr2",
      "end": 29222345,
      "ref": "C",
      "CADD": 0.17,
      "REVEL": 0.91,
      "start": 29222772,
      "SIFT4G": 0.39,
      "GenBank": "NM_004304",
      "PROVEAN": 0.62,
      "variant": "Q1940E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.17,
      "fathmm-MKL": 0.89,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.13],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.01],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.07],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.09
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.04, -0.44, -0.56],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.25,
            "FE_Bind_mean": -0.88
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.99, -1.04, -0.29],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.71
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.48, -0.88, -0.87],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.88,
            "FE_Bind_mean": -0.57
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.63,
      "Polyphen2_HDIV": 0.59,
      "Polyphen2_HVAR": 0.65,
      "MutationAssessor": 0.52,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.87,
      "alt": "A",
      "chr": "chr2",
      "end": 29222905,
      "ref": "G",
      "CADD": 0.26,
      "REVEL": 0.27,
      "start": 29222711,
      "SIFT4G": 0.04,
      "GenBank": "NM_004304",
      "PROVEAN": 0.95,
      "variant": "Q1486A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.96,
      "fathmm-MKL": 0.62,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.14],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.65
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.13],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.84
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.15],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.34
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.93, -0.46, -1.04],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.84,
            "FE_Bind_mean": -0.25
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.18, -0.98, -0.76],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -0.98
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.88, -0.54, -1.14],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.54,
            "FE_Bind_mean": -0.59
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.73,
      "Polyphen2_HDIV": 0.32,
      "Polyphen2_HVAR": 0.55,
      "MutationAssessor": 0.32,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.66,
      "alt": "C",
      "chr": "chr2",
      "end": 29222805,
      "ref": "A",
      "CADD": 0.33,
      "REVEL": 0.43,
      "start": 29222554,
      "SIFT4G": 0.34,
      "GenBank": "NM_004304",
      "PROVEAN": 0.22,
      "variant": "Q8132V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.44,
      "fathmm-MKL": 0.73,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.66],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.04
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.05],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.14
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.73],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.83
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.82, -1.15, -0.69],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.51,
            "FE_Bind_mean": -1.16
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.54, -0.32, -0.53],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.67,
            "FE_Bind_mean": -0.45
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.63, -0.29, -0.99],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.22,
            "FE_Bind_mean": -1.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.58,
      "Polyphen2_HDIV": 0.21,
      "Polyphen2_HVAR": 0.55,
      "MutationAssessor": 0.31,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.39,
      "alt": "A",
      "chr": "chr2",
      "end": 29222788,
      "ref": "C",
      "CADD": 0.54,
      "REVEL": 0.06,
      "start": 29222671,
      "SIFT4G": 0.24,
      "GenBank": "NM_004304",
      "PROVEAN": 0.35,
      "variant": "C9963K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.24,
      "fathmm-MKL": 0.66,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.39],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.47
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.39],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.24],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.17
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.24, -0.87, -0.63],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.39,
            "FE_Bind_mean": -0.47
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.06, -0.03, -1.06],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -0.23
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.89, -0.09, -0.93],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.69,
            "FE_Bind_mean": -1.07
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.18,
      "Polyphen2_HDIV": 0.63,
      "Polyphen2_HVAR": 0.55,
      "MutationAssessor": 0.33,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.05,
      "alt": "C",
      "chr": "chr2",
      "end": 29222390,
      "ref": "A",
      "CADD": 0.91,
      "REVEL": 0.18,
      "start": 29222795,
      "SIFT4G": 0.16,
      "GenBank": "NM_004304",
      "PROVEAN": 0.18,
      "variant": "A3982V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.92,
      "fathmm-MKL": 0.66,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.17],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.67
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.08],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.48
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.62],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.19
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.98, -0.22, -0.14],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.75,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.19, -0.03, -0.67],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.67,
            "FE_Bind_mean": -0.15
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.65, -0.94, -0.55],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.22,
            "FE_Bind_mean": -0.18
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.65,
      "Polyphen2_HDIV": 0.88,
      "Polyphen2_HVAR": 0.85,
      "MutationAssessor": 0.05,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.02,
      "alt": "C",
      "chr": "chr2",
      "end": 29222192,
      "ref": "C",
      "CADD": 0.79,
      "REVEL": 0.17,
      "start": 29222586,
      "SIFT4G": 0.15,
      "GenBank": "NM_004304",
      "PROVEAN": 0.18,
      "variant": "I9795A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.86,
      "fathmm-MKL": 0.78,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.68],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.62
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.32],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.21
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.05, -1.16, -1.04],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.03,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.09, -0.89, -0.76],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.47,
            "FE_Bind_mean": -0.34
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.98, -0.88, -0.06],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.19,
            "FE_Bind_mean": -0.29
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.62,
      "Polyphen2_HDIV": 0.14,
      "Polyphen2_HVAR": 0.02,
      "MutationAssessor": 0.39,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.48,
      "alt": "T",
      "chr": "chr2",
      "end": 29222767,
      "ref": "G",
      "CADD": 0.55,
      "REVEL": 0.93,
      "start": 29222477,
      "SIFT4G": 0.36,
      "GenBank": "NM_004304",
      "PROVEAN": 0.64,
      "variant": "I5508A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.36,
      "fathmm-MKL": 0.78,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.39],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.24
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.85],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.97
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.94],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.25
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.64, -0.27, -0.01],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -0.87
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.44, -1.03, -0.88],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.83,
            "FE_Bind_mean": -0.42
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.35, -0.95, -0.39],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.45,
            "FE_Bind_mean": -0.24
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.56,
      "Polyphen2_HDIV": 0.14,
      "Polyphen2_HVAR": 0.55,
      "MutationAssessor": 0.08,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.41,
      "alt": "G",
      "chr": "chr2",
      "end": 29222093,
      "ref": "C",
      "CADD": 0.26,
      "REVEL": 0.98,
      "start": 29222090,
      "SIFT4G": 0.08,
      "GenBank": "NM_004304",
      "PROVEAN": 0.34,
      "variant": "A7450A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.02,
      "fathmm-MKL": 0.65,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.56],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.14
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.07],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.49
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.08],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.82
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.32, -0.12, -1.01],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.28,
            "FE_Bind_mean": -0.94
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.09, -0.01, -0.53],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.32,
            "FE_Bind_mean": -0.61
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.46, -0.98, -1.18],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.51,
            "FE_Bind_mean": -0.77
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.85,
      "Polyphen2_HDIV": 0.65,
      "Polyphen2_HVAR": 0.35,
      "MutationAssessor": 0.21,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.99,
      "alt": "C",
      "chr": "chr2",
      "end": 29222167,
      "ref": "C",
      "CADD": 0.28,
      "REVEL": 0.72,
      "start": 29222536,
      "SIFT4G": 0.14,
      "GenBank": "NM_004304",
      "PROVEAN": 0.83,
      "variant": "B9783R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.35,
      "fathmm-MKL": 0.71,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.74],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.73
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.23],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.12
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.89],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.38
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.44, -1.13, -0.89],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.38,
            "FE_Bind_mean": -0.44
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.72, -0.08, -0.16],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.62,
            "FE_Bind_mean": -0.19
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.47, -1.15, -0.56],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.73,
            "FE_Bind_mean": -1.14
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.55,
      "Polyphen2_HDIV": 0.92,
      "Polyphen2_HVAR": 0.29,
      "MutationAssessor": 0.73,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.81,
      "alt": "T",
      "chr": "chr2",
      "end": 29222812,
      "ref": "G",
      "CADD": 0.99,
      "REVEL": 0.52,
      "start": 29222821,
      "SIFT4G": 0.32,
      "GenBank": "NM_004304",
      "PROVEAN": 0.19,
      "variant": "C2368A",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.65,
      "fathmm-MKL": 0.77,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.02],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.55
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.03],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.84
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.28],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.43
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.57, -0.19, -0.32],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.87,
            "FE_Bind_mean": -1.16
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.91, -0.07, -0.65],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.31,
            "FE_Bind_mean": -0.63
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.07, -1.19, -0.35],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.53,
            "FE_Bind_mean": -0.07
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.75,
      "Polyphen2_HDIV": 0.38,
      "Polyphen2_HVAR": 0.95,
      "MutationAssessor": 0.01,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.35,
      "alt": "T",
      "chr": "chr2",
      "end": 29222342,
      "ref": "A",
      "CADD": 0.96,
      "REVEL": 0.79,
      "start": 29222434,
      "SIFT4G": 0.37,
      "GenBank": "NM_004304",
      "PROVEAN": 0.92,
      "variant": "L8434M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.54,
      "fathmm-MKL": 0.78,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.27],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.47],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.96
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.33],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.01, -1.16, -0.63],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.37,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.23, -0.47, -0.64],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.28,
            "FE_Bind_mean": -0.58
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.69, -1.13, -0.28],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.53,
            "FE_Bind_mean": -1.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.11,
      "Polyphen2_HDIV": 0.95,
      "Polyphen2_HVAR": 0.47,
      "MutationAssessor": 0.65,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.59,
      "alt": "C",
      "chr": "chr2",
      "end": 29222415,
      "ref": "G",
      "CADD": 0.17,
      "REVEL": 0.32,
      "start": 29222378,
      "SIFT4G": 0.74,
      "GenBank": "NM_004304",
      "PROVEAN": 0.15,
      "variant": "C1124R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.14,
      "fathmm-MKL": 0.71,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.61],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.16
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.64],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.45
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.16],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.04
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.01, -0.46, -1.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -1.17
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.13, -1.06, -0.67],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.08,
            "FE_Bind_mean": -0.74
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.02, -0.69, -0.93],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.42,
            "FE_Bind_mean": -0.48
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.33,
      "Polyphen2_HDIV": 0.67,
      "Polyphen2_HVAR": 0.84,
      "MutationAssessor": 0.77,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.21,
      "alt": "C",
      "chr": "chr2",
      "end": 29222577,
      "ref": "G",
      "CADD": 0.19,
      "REVEL": 0.89,
      "start": 29222891,
      "SIFT4G": 0.67,
      "GenBank": "NM_004304",
      "PROVEAN": 0.22,
      "variant": "B2019R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.57,
      "fathmm-MKL": 0.95,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.19],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.05
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.39],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.43],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.01
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.83, -0.31, -0.36],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.09,
            "FE_Bind_mean": -1.18
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.62, -0.31, -0.39],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.49,
            "FE_Bind_mean": -0.78
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.96, -1.17, -0.14],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.02,
            "FE_Bind_mean": -0.33
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.71,
      "Polyphen2_HDIV": 0.35,
      "Polyphen2_HVAR": 0.76,
      "MutationAssessor": 0.56,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.06,
      "alt": "A",
      "chr": "chr2",
      "end": 29222462,
      "ref": "A",
      "CADD": 0.07,
      "REVEL": 0.91,
      "start": 29222871,
      "SIFT4G": 0.87,
      "GenBank": "NM_004304",
      "PROVEAN": 0.93,
      "variant": "Q6442M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.52,
      "fathmm-MKL": 0.98,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.69],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.54
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.98],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.01
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.09],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.13
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.03, -0.19, -0.97],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.18, -0.27, -0.03],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -0.16
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.37, -0.07, -0.83],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.03,
            "FE_Bind_mean": -1.13
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.71,
      "Polyphen2_HDIV": 0.23,
      "Polyphen2_HVAR": 0.48,
      "MutationAssessor": 0.81,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.56,
      "alt": "G",
      "chr": "chr2",
      "end": 29222506,
      "ref": "G",
      "CADD": 0.74,
      "REVEL": 0.71,
      "start": 29222679,
      "SIFT4G": 0.88,
      "GenBank": "NM_004304",
      "PROVEAN": 0.95,
      "variant": "C9268R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.96,
      "fathmm-MKL": 0.76,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.73],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.76
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.54],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.35
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.01],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.97
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.85, -0.91, -0.68],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.01, -1.14, -0.19],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.89,
            "FE_Bind_mean": -0.48
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.58, -0.92, -0.22],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.65,
            "FE_Bind_mean": -0.65
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.76,
      "Polyphen2_HDIV": 0.37,
      "Polyphen2_HVAR": 0.19,
      "MutationAssessor": 0.34,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.49,
      "alt": "C",
      "chr": "chr2",
      "end": 29222112,
      "ref": "C",
      "CADD": 0.63,
      "REVEL": 0.81,
      "start": 29222372,
      "SIFT4G": 0.28,
      "GenBank": "NM_004304",
      "PROVEAN": 0.71,
      "variant": "A6534E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.52,
      "fathmm-MKL": 0.64,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.96],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.45
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.53],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.86
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.15],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.27
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.17, -0.65, -1.01],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.15,
            "FE_Bind_mean": -1.11
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.15, -1.07, -0.83],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.27,
            "FE_Bind_mean": -0.88
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.18, -0.95, -0.82],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -0.69
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.33,
      "Polyphen2_HDIV": 0.67,
      "Polyphen2_HVAR": 0.78,
      "MutationAssessor": 0.59,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.14,
      "alt": "C",
      "chr": "chr2",
      "end": 29222966,
      "ref": "A",
      "CADD": 0.49,
      "REVEL": 0.05,
      "start": 29222526,
      "SIFT4G": 0.36,
      "GenBank": "NM_004304",
      "PROVEAN": 0.48,
      "variant": "I3539R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.54,
      "fathmm-MKL": 0.71,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.26],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.11
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.26],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.75
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.11],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.37
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.14, -0.04, -0.07],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.55,
            "FE_Bind_mean": -1.13
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.33, -0.61, -0.81],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.33,
            "FE_Bind_mean": -0.06
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.01, -1.07, -0.44],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.61,
            "FE_Bind_mean": -0.78
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.95,
      "Polyphen2_HDIV": 0.01,
      "Polyphen2_HVAR": 0.65,
      "MutationAssessor": 0.06,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.77,
      "alt": "C",
      "chr": "chr2",
      "end": 29222605,
      "ref": "G",
      "CADD": 0.02,
      "REVEL": 0.23,
      "start": 29222261,
      "SIFT4G": 0.35,
      "GenBank": "NM_004304",
      "PROVEAN": 0.88,
      "variant": "A8045V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.17,
      "fathmm-MKL": 0.82,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.31],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.98
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.17],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.63],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.38
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.57, -0.88, -0.25],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.64,
            "FE_Bind_mean": -0.02
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.14, -1.15, -0.85],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.12,
            "FE_Bind_mean": -1.01
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.73, -0.21, -0.16],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.53,
            "FE_Bind_mean": -1.09
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.98,
      "Polyphen2_HDIV": 0.26,
      "Polyphen2_HVAR": 0.57,
      "MutationAssessor": 0.85,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.65,
      "alt": "T",
      "chr": "chr2",
      "end": 29222233,
      "ref": "G",
      "CADD": 0.39,
      "REVEL": 0.79,
      "start": 29222690,
      "SIFT4G": 0.85,
      "GenBank": "NM_004304",
      "PROVEAN": 0.55,
      "variant": "L7548R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.77,
      "fathmm-MKL": 0.86,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.57],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.54
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.31],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.26
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.03],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.06
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.05, -0.79, -0.32],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.25,
            "FE_Bind_mean": -0.71
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.24, -0.71, -1.02],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.66,
            "FE_Bind_mean": -0.17
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.53, -0.47, -0.64],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.41,
            "FE_Bind_mean": -0.98
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.74,
      "Polyphen2_HDIV": 0.53,
      "Polyphen2_HVAR": 0.48,
      "MutationAssessor": 0.92,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.63,
      "alt": "T",
      "chr": "chr2",
      "end": 29222904,
      "ref": "G",
      "CADD": 0.55,
      "REVEL": 0.93,
      "start": 29222442,
      "SIFT4G": 0.76,
      "GenBank": "NM_004304",
      "PROVEAN": 0.64,
      "variant": "P7632M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.32,
      "fathmm-MKL": 0.89,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.28],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.36
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.82],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.05],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.21
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.93, -0.98, -1.04],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -0.54
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.36, -0.25, -0.01],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.32,
            "FE_Bind_mean": -0.08
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.45, -0.96, -0.56],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.72,
            "FE_Bind_mean": -0.75
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.27,
      "Polyphen2_HDIV": 0.69,
      "Polyphen2_HVAR": 0.88,
      "MutationAssessor": 0.36,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Conflicting interpretations of pathogenicity"
      ]
    },
    {
      "LRT": 0.73,
      "alt": "G",
      "chr": "chr2",
      "end": 29222514,
      "ref": "G",
      "CADD": 0.48,
      "REVEL": 0.35,
      "start": 29222444,
      "SIFT4G": 0.99,
      "GenBank": "NM_004304",
      "PROVEAN": 0.95,
      "variant": "P7196M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.65,
      "fathmm-MKL": 0.75,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.81],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.15
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.46],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.45
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.88],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.69
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.52, -0.38, -0.22],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.29,
            "FE_Bind_mean": -0.93
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.46, -0.53, -0.62],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.11,
            "FE_Bind_mean": -0.75
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.44, -1.03, -0.45],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.71,
            "FE_Bind_mean": -1.05
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.79,
      "Polyphen2_HDIV": 0.38,
      "Polyphen2_HVAR": 0.94,
      "MutationAssessor": 0.05,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.96,
      "alt": "A",
      "chr": "chr2",
      "end": 29222688,
      "ref": "C",
      "CADD": 0.09,
      "REVEL": 0.29,
      "start": 29222435,
      "SIFT4G": 0.52,
      "GenBank": "NM_004304",
      "PROVEAN": 0.08,
      "variant": "C9878E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.62,
      "fathmm-MKL": 0.72,
      "Compound_ID": "lorlatinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.04],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.89
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.47],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.03],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.45
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.22, -0.47, -0.13],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.12,
            "FE_Bind_mean": -0.07
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.11, -0.63, -1.01],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.11,
            "FE_Bind_mean": -1.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.16, -0.14, -0.89],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.77,
            "FE_Bind_mean": -1.17
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.78,
      "Polyphen2_HDIV": 0.48,
      "Polyphen2_HVAR": 0.01,
      "MutationAssessor": 0.65,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.35,
      "alt": "T",
      "chr": "chr2",
      "end": 29222355,
      "ref": "C",
      "CADD": 0.64,
      "REVEL": 0.11,
      "start": 29222441,
      "SIFT4G": 0.28,
      "GenBank": "NM_004304",
      "PROVEAN": 0.89,
      "variant": "Q2146V",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.82,
      "fathmm-MKL": 0.87,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.02],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.42
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.18],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.42
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.58],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.53
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.54, -0.49, -0.52],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.21,
            "FE_Bind_mean": -0.24
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.85, -0.22, -0.45],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.54,
            "FE_Bind_mean": -0.78
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.34, -0.87, -0.23],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.78,
            "FE_Bind_mean": -0.12
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.86,
      "Polyphen2_HDIV": 0.27,
      "Polyphen2_HVAR": 0.15,
      "MutationAssessor": 0.68,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.85,
      "alt": "G",
      "chr": "chr2",
      "end": 29222935,
      "ref": "A",
      "CADD": 0.62,
      "REVEL": 0.52,
      "start": 29222624,
      "SIFT4G": 0.09,
      "GenBank": "NM_004304",
      "PROVEAN": 0.25,
      "variant": "C5075M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.77,
      "fathmm-MKL": 0.76,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.85],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.97
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.02],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.09
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.04],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.48
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.76, -0.69, -0.56],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -1.11
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.23, -0.07, -0.44],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.68,
            "FE_Bind_mean": -0.52
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.94, -0.73, -0.79],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.54,
            "FE_Bind_mean": -0.51
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.62,
      "Polyphen2_HDIV": 0.64,
      "Polyphen2_HVAR": 0.42,
      "MutationAssessor": 0.44,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.81,
      "alt": "C",
      "chr": "chr2",
      "end": 29222957,
      "ref": "G",
      "CADD": 0.96,
      "REVEL": 0.61,
      "start": 29222653,
      "SIFT4G": 0.33,
      "GenBank": "NM_004304",
      "PROVEAN": 0.67,
      "variant": "B1489K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.91,
      "fathmm-MKL": 0.72,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.11],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.74
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.06],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.16
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.67],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.92
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.19, -0.63, -1.15],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.23,
            "FE_Bind_mean": -0.94
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.67, -0.39, -0.83],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.36,
            "FE_Bind_mean": -0.27
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.94, -0.41, -1.06],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.19,
            "FE_Bind_mean": -0.76
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.14,
      "Polyphen2_HDIV": 0.49,
      "Polyphen2_HVAR": 0.34,
      "MutationAssessor": 0.27,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.18,
      "alt": "C",
      "chr": "chr2",
      "end": 29222731,
      "ref": "C",
      "CADD": 0.48,
      "REVEL": 0.09,
      "start": 29222757,
      "SIFT4G": 0.56,
      "GenBank": "NM_004304",
      "PROVEAN": 0.98,
      "variant": "I2049R",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.58,
      "fathmm-MKL": 0.86,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.42],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.92
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.22],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.91
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.43],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.83
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.65, -0.53, -0.83],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.24,
            "FE_Bind_mean": -0.39
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.24, -0.02, -0.96],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.74,
            "FE_Bind_mean": -0.32
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.57, -0.19, -0.24],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.37,
            "FE_Bind_mean": -0.76
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.38,
      "Polyphen2_HDIV": 0.84,
      "Polyphen2_HVAR": 0.56,
      "MutationAssessor": 0.74,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": ["Uncertain significance"]
    },
    {
      "LRT": 0.13,
      "alt": "C",
      "chr": "chr2",
      "end": 29222242,
      "ref": "C",
      "CADD": 0.63,
      "REVEL": 0.27,
      "start": 29222503,
      "SIFT4G": 0.31,
      "GenBank": "NM_004304",
      "PROVEAN": 0.37,
      "variant": "L8209M",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.32,
      "fathmm-MKL": 0.97,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.38],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.43
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.24],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.87
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.79],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.79
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.18, -0.17, -0.99],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.46,
            "FE_Bind_mean": -1.08
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.04, -1.02, -0.67],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.61,
            "FE_Bind_mean": -0.72
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.32, -0.73, -0.87],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.27,
            "FE_Bind_mean": -0.38
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.52,
      "Polyphen2_HDIV": 0.94,
      "Polyphen2_HVAR": 0.75,
      "MutationAssessor": 0.26,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    },
    {
      "LRT": 0.49,
      "alt": "T",
      "chr": "chr2",
      "end": 29222425,
      "ref": "C",
      "CADD": 0.84,
      "REVEL": 0.67,
      "start": 29222812,
      "SIFT4G": 0.36,
      "GenBank": "NM_004304",
      "PROVEAN": 0.68,
      "variant": "A1338K",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.73,
      "fathmm-MKL": 0.72,
      "Compound_ID": "alectinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.91],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.43
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.16],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.63
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.95],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -1.01
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.34, -1.07, -0.69],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.22,
            "FE_Bind_mean": -0.23
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-1.17, -1.01, -0.08],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -0.13
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.31, -0.74, -0.26],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.19,
            "FE_Bind_mean": -0.45
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.74,
      "Polyphen2_HDIV": 0.38,
      "Polyphen2_HVAR": 0.36,
      "MutationAssessor": 0.76,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": ["not provided"],
      "ClinVar_ClinicalSignificance": [
        "Pathogenic/Likely pathogenic",
        " risk factor"
      ]
    },
    {
      "LRT": 0.12,
      "alt": "G",
      "chr": "chr2",
      "end": 29222296,
      "ref": "A",
      "CADD": 0.65,
      "REVEL": 0.64,
      "start": 29222530,
      "SIFT4G": 0.15,
      "GenBank": "NM_004304",
      "PROVEAN": 0.36,
      "variant": "A6442E",
      "assembly": "hg38",
      "genename": "ALK",
      "PrimateAI": 0.04,
      "fathmm-MKL": 0.88,
      "Compound_ID": "crizotinib",
      "calculation": {
        "MP-CAFEE": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-1.03],
            "Compound_ID": "alectinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.22
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.69],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.28
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-1.14],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": null,
            "FE_Bind_mean": -0.52
          }
        ],
        "Mutation_FEP": [
          {
            "PDB_ID": "3aox",
            "FE_Bind": [-0.94, -0.93, -0.92],
            "Compound_ID": "alectinib",
            "FE_Bind_std": -0.51,
            "FE_Bind_mean": -0.95
          },
          {
            "PDB_ID": "2xp2",
            "FE_Bind": [-0.11, -0.19, -0.17],
            "Compound_ID": "crizotinib",
            "FE_Bind_std": -0.55,
            "FE_Bind_mean": -1.15
          },
          {
            "PDB_ID": "4cli",
            "FE_Bind": [-0.71, -0.57, -0.52],
            "Compound_ID": "lorlatinib",
            "FE_Bind_std": -0.48,
            "FE_Bind_mean": -0.79
          }
        ]
      },
      "uniprot_acc": "Q9UM73",
      "MutationTaster": 0.28,
      "Polyphen2_HDIV": 0.75,
      "Polyphen2_HVAR": 0.03,
      "MutationAssessor": 0.27,
      "PDBlist_single_wild": [
        "6edl",
        "4ccu",
        "5imx",
        "4ctc",
        "4ccb",
        "4tt7",
        "6cdt",
        "4ctb"
      ],
      "MGeND_ClinicalSignificance": [],
      "ClinVar_ClinicalSignificance": []
    }
  ],
  "size": 100
}
